The SURMOUNT-1 trial (tirzepatide, similar population) reported average weight loss up to about 20.9 percent at the highest dose over 72 weeks (Jastreboff AM, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Hsieh M.J., Liu H.T., Wang C.N., Huang H.Y., Lin Y., Ko Y.S., Wang J.S., Chang V.H., Pang J.S
Eating a lot of red meat, smoking and not getting enough movement are also believed to be risk factors
In its report this year, the National Association of Boards of Pharmacy said the FDAs Adverse Event Reporting System found 42 people around the world had been hospitalized after being injected with substandard or falsified semaglutide
XX wieku w badaniach zespou Predraga Sikia i wsppracownikw z Uniwersytetu w Zagrzebiu (Siki et al., Journal of Physiology , 1993)
Clinical studies show an average weight reduction of 15% over 68 weeks